Status:
UNKNOWN
Molecular Genetic Screening and Identification of Congenital Arrhythmogenic Diseases
Lead Sponsor:
Heidelberg University
Conditions:
Long QT Syndrome
Hypertrophic Cardiomyopathy
Eligibility:
All Genders
Brief Summary
The aim of this study is the identification of familial congenital arrhythmogenic disorders and their clinical follow-up.
Detailed Description
Molecular genetic screening in patients with: * supraventricular * ventricular arrhythmia * syncopes of unknown origin and/or suspicion of an arrhythmogenic origin * family members of patients with s...
Eligibility Criteria
Inclusion
- Patients with a history of syncope, abnormal ECG and suspicion of an arrhythmogenic disease
- Patients with long QT syndrome
- Patients with short QT syndrome, shortened QT intervals, borderline shortened QT intervals
- Patients with Brugada syndrome
- Patients with hypertrophic cardiomyopathy
- Patients with arrhythmogenic right ventricular dysplasia
Exclusion
- Inability to understand study protocol
Key Trial Info
Start Date :
October 1 2003
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2011
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT00221832
Start Date
October 1 2003
End Date
December 1 2011
Last Update
January 13 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Mannheim, I. Department of Medicine
Mannheim, Germany, 68167